Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2390771944;71945;71946 chr2:178574413;178574412;178574411chr2:179439140;179439139;179439138
N2AB2226667021;67022;67023 chr2:178574413;178574412;178574411chr2:179439140;179439139;179439138
N2A2133964240;64241;64242 chr2:178574413;178574412;178574411chr2:179439140;179439139;179439138
N2B1484244749;44750;44751 chr2:178574413;178574412;178574411chr2:179439140;179439139;179439138
Novex-11496745124;45125;45126 chr2:178574413;178574412;178574411chr2:179439140;179439139;179439138
Novex-21503445325;45326;45327 chr2:178574413;178574412;178574411chr2:179439140;179439139;179439138
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCA
  • RefSeq wild type template codon: CGT
  • Domain: Fn3-61
  • Domain position: 82
  • Structural Position: 114
  • Q(SASA): 0.527
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/T rs1309139547 -0.417 0.977 N 0.74 0.385 0.301455362545 gnomAD-2.1.1 3.19E-05 None None None None I None 0 0 None 0 0 None 0 None 0 6.48E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.8164 likely_pathogenic 0.7933 pathogenic -0.832 Destabilizing 1.0 D 0.799 deleterious None None None None I
A/D 0.9805 likely_pathogenic 0.9799 pathogenic -0.903 Destabilizing 0.999 D 0.841 deleterious None None None None I
A/E 0.9569 likely_pathogenic 0.9539 pathogenic -1.064 Destabilizing 0.997 D 0.794 deleterious N 0.498271678 None None I
A/F 0.9011 likely_pathogenic 0.869 pathogenic -1.029 Destabilizing 0.998 D 0.863 deleterious None None None None I
A/G 0.4224 ambiguous 0.4305 ambiguous -0.473 Destabilizing 0.989 D 0.639 neutral N 0.491928575 None None I
A/H 0.9738 likely_pathogenic 0.9646 pathogenic -0.426 Destabilizing 1.0 D 0.848 deleterious None None None None I
A/I 0.6557 likely_pathogenic 0.6662 pathogenic -0.497 Destabilizing 0.966 D 0.717 prob.delet. None None None None I
A/K 0.9829 likely_pathogenic 0.9791 pathogenic -0.858 Destabilizing 0.998 D 0.794 deleterious None None None None I
A/L 0.6971 likely_pathogenic 0.6873 pathogenic -0.497 Destabilizing 0.966 D 0.579 neutral None None None None I
A/M 0.7523 likely_pathogenic 0.7335 pathogenic -0.479 Destabilizing 0.999 D 0.801 deleterious None None None None I
A/N 0.9453 likely_pathogenic 0.937 pathogenic -0.515 Destabilizing 0.999 D 0.86 deleterious None None None None I
A/P 0.9646 likely_pathogenic 0.9672 pathogenic -0.441 Destabilizing 0.999 D 0.798 deleterious N 0.519164317 None None I
A/Q 0.9394 likely_pathogenic 0.9248 pathogenic -0.849 Destabilizing 0.999 D 0.81 deleterious None None None None I
A/R 0.9502 likely_pathogenic 0.9356 pathogenic -0.267 Destabilizing 0.998 D 0.811 deleterious None None None None I
A/S 0.3252 likely_benign 0.3129 benign -0.667 Destabilizing 0.989 D 0.629 neutral N 0.474700147 None None I
A/T 0.5601 ambiguous 0.5866 pathogenic -0.759 Destabilizing 0.977 D 0.74 deleterious N 0.513377419 None None I
A/V 0.3008 likely_benign 0.2943 benign -0.441 Destabilizing 0.235 N 0.447 neutral N 0.46787941 None None I
A/W 0.9885 likely_pathogenic 0.9836 pathogenic -1.137 Destabilizing 1.0 D 0.843 deleterious None None None None I
A/Y 0.953 likely_pathogenic 0.9371 pathogenic -0.823 Destabilizing 0.999 D 0.863 deleterious None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.